1408000-52-1

Basic information

• Product Name: 3-azido-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)benzamide
• Synonyms: 3-azido-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)benzamide
• CAS NO: 1408000-52-1
• Molecular Weight: 400.363
• Mol File: 1408000-52-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 3-azido-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 3-azido-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)benzamide(1408000-52-1)
• EPA Substance Registry System: 3-azido-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)benzamide(1408000-52-1)

Safety Data

• Hazardous Substances Data: 1408000-52-1(Hazardous Substances Data)

Upstream product

• 641571-11-1 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)aniline 
• 855304-57-3 methyl 3-azido-4-methylbenzoate 
• 18595-18-1 3-amino-4-methyl benzoic acid methyl ester 
• 54962-75-3 [3-bromo-5-(trifluoromethyl)phenyl]amine 

Downstream Products

• 1408000-15-6 C₂₇H₂₀F₃N₉O 

Relevant articles and documents

Heterocyclic benzoyl amide compounds, medicinal composition and use thereof

The invention discloses heterocyclic benzamide compounds with structural characteristics of formula (1) or pharmaceutically acceptable salts or steric isomers or prodrug molecules thereof. The heterocyclic benzamide compounds as well as pharmaceutically acceptable salts thereof can effectively restrain growth of a plurality of tumor cells, can generate inhibiting effect to proteases such as BCR-ABL, c-Kit and PDGFR, can be used for preparing anti-tumor drugs and can be used for overcoming existing drug (Gleevec)-induced drug resistance.